A critical question facing a company's ability to grow its business internationally is where it should go next. One company facing that decision was GENICON, a U.S.-based firm that manufactured and distributed medical instruments for laparoscopic surgeries. Although the minimally invasive surgical market in the United States had long been the largest in the world, international markets were anticipated to grow at a much faster rate than the U.S. .....more

Teaching note for product 9B14M076.

The chief executive officer (CEO) of GENICON is at a crossroads. The private medical device manufacturing business he started over 15 years ago has several acquisition offers as the industry starts to consolidate ahead of changes to the U.S. healthcare system. He can sell it now and make millions for himself and his investors or he can grow the business for a couple more years and, assuming a constant multiple of acquisition price to revenue, make .....more

Teaching note for product 9B12M116.

A U.S. medical device manufacturer is operating in more than 40 international markets, including its most recent entries in the BRIC markets. The company president is now ready to look to new emerging markets for revenue growth. This time a more advanced “post-BRIC” analysis is needed to determine which market to enter next. Because the capital investment and risk associated with entering a new market is high, making the right market selection is .....more

A critical question facing a company's ability to grow its business internationally is where it should go next. One company facing that decision was GENICON, a U.S.-based firm that manufactured and distributed medical instruments for laparoscopic surgeries. Although the minimally invasive surgical market in the United States had long been the largest in the world, international markets were anticipated to grow at a much faster rate than the U.S. .....more

Teaching note for product 9B10M041.